$92.74
0.15% yesterday
NYSE, Aug 11, 10:02 pm CET
ISIN
IE00BTN1Y115
Symbol
MDT

Medtronic Stock price

$92.74
+2.82 3.14% 1M
+1.54 1.69% 6M
+12.86 16.10% YTD
+11.55 14.23% 1Y
-1.30 1.38% 3Y
-7.98 7.92% 5Y
+15.35 19.83% 10Y
+38.11 69.76% 20Y
NYSE, Closing price Mon, Aug 11 2025
-0.14 0.15%

Key metrics

Basic
Market capitalization
$118.8b
Enterprise Value
$138.4b
Net debt
$19.6b
Cash
$9.0b
Shares outstanding
1.3b
Valuation (TTM | estimate)
P/E
25.6 | 16.5
P/S
3.5 | 3.3
EV/Sales
4.1 | 3.9
EV/FCF
26.7
P/B
2.5
Dividends
DPS
$2.80
Yield 1Y | 5Y
3.0% | 2.7%
Growth 1Y | 5Y
1.4% | 5.3%
Payout 1Y | 3Y
77.6% | 90.1%
Increased
25 Years
Financials (TTM | estimate)
Revenue
$33.5b | $35.7b
EBITDA
$8.4b | $10.3b
EBIT
$6.6b | $9.0b
Net Income
$4.7b | $7.2b
Free Cash Flow
$5.2b
Growth (TTM | estimate)
Revenue
3.6% | 6.3%
EBITDA
7.3% | 23.1%
EBIT
7.4% | 37.4%
Net Income
26.8% | 54.2%
Free Cash Flow
-0.3%
Margin (TTM | estimate)
Gross
65.4%
EBITDA
25.0% | 28.9%
EBIT
19.6%
Net
13.9% | 20.2%
Free Cash Flow
15.5%
Financial Health
Equity Ratio
52.4%
Return on Equity
9.7%
ROCE
8.3%
ROIC
7.0%
Debt/Equity
0.6
More
EPS
$3.6
FCF per Share
$4.0
Short interest
1.0%
Employees
95k
Rev per Employee
$350.0k
Show more

Is Medtronic a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Medtronic Stock Analysis

Unlock Scores for Free

Analyst Opinions

39 Analysts have issued a Medtronic forecast:

21x Buy
54%
17x Hold
44%
1x Sell
3%

Analyst Opinions

39 Analysts have issued a Medtronic forecast:

Buy
54%
Hold
44%
Sell
3%

Financial data from Medtronic

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Apr '25
+/-
%
33,537 33,537
4% 4%
100%
- Direct Costs 11,607 11,607
5% 5%
35%
21,930 21,930
3% 3%
65%
- Selling and Administrative Expenses 10,838 10,838
2% 2%
32%
- Research and Development Expense 2,732 2,732
0% 0%
8%
8,382 8,382
7% 7%
25%
- Depreciation and Amortization 1,807 1,807
7% 7%
5%
EBIT (Operating Income) EBIT 6,575 6,575
7% 7%
20%
Net Profit 4,662 4,662
27% 27%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Medtronic directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medtronic Stock News

Positive
The Motley Fool
about 5 hours ago
Dividend Kings are the most durable dividend stocks, having increased their payouts annually for at least 50 consecutive years. This resilience is impressive, as they've weathered at least seven recessions in that time.
Positive
Market Watch
about 18 hours ago
Companies that are increasing their dividends are good bets to hold their own during the next economic downturn.
Neutral
PRNewsWire
7 days ago
GALWAY, Ireland , Aug. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025, A news release containing summary financial information will be issued at approximately 5:45 a.m. Central Daylight Ti...
More Medtronic News

Company Profile

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Head office United States
CEO Geoffrey Martha
Employees 95,000
Founded 2014
Website www.medtronic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today